An uncertified class action lawsuit filed in Calgary accuses major LPs of selling products whose THC and CBD contents are “drastically different” than are listed on containers. Among the defendants are LPs (or related entities) Aurora, Aleafia, Hexo, Cronos, Tilray, Organigram, and Medipharm.
Cannabis Law Report, Global News, Twitter–@MattPMaurer
- Plaintiff Lisa Marie Langevin bought a Tilray oil product but felt no effect on multiple uses. Lab analysis revealed the oil contained only 46% of the THC listed on the bottle. A second sample from the same lot contained 79% of the listed THC. (More details here.)
Twitter–@WhatsMyPot - Samples by several producers were tested by an independent lab: six had THC levels dramatically different than the amounts listed on the package. Two were much stronger, as much as 119% the listed THC content. Others were weaker. These allegations have not been proven.
Twitter–@Cain, @MattPMaurer
Defendants have yet to respond, but will likely argue the product contents were accurate at the time of packaging.
Twitter–@MattPMaurer
- Early research suggests plastic containers may absorb cannabinoids.
Twitter–@MattPMaurer - Lawyer Matt Maurer breaks down the suit in far greater detail in this twitter thread, while BNN Bloomberg‘s David George-Cosh offered a few non-editorializing thoughts here.
Twitter–@MattPMaurer, @itsDGC
